SOPH insider plans option and share sales

The filing for SOPH reports a planned sale of common stock by insider Jurgi Camblong.

Rhea-AI Filing Summary

The filing for SOPH reports a planned sale of common stock by insider Jurgi Camblong. The notice lists 4,581 common shares to be sold following an exercise of stock options dated July 20, 2026, and an additional 19,800 founder shares dated March 18, 2021.

The sales are arranged through Morgan Stanley Smith Barney LLC Executive Financial Services and reference prior activity under a Rule 10b5-1 trading plan. Recent plan sales include 65,269 shares for $398,632.27 on June 30, 2026 and 50,069 shares for $290,329.01 on June 26, 2026, alongside multiple smaller transactions in May, June, and July 2026.

Key Figures

Shares from option exercise: 4,581 shares Founder shares to be sold: 19,800 shares 10b5-1 sale on June 30, 2026: 65,269 shares for $398,632.27 +2 more

5 metrics

Shares from option exercise 4,581 shares Common shares to be sold from Exercise of Stock Options dated July 20, 2026

Founder shares to be sold 19,800 shares Founder shares of common stock dated March 18, 2021 included in planned sales

10b5-1 sale on June 30, 2026 65,269 shares for $398,632.27 Common stock sold as a 10b5-1 Sale for Jurgi Camblong

10b5-1 sale on June 26, 2026 50,069 shares for $290,329.01 Common stock sold under 10b5-1 trading plan for Jurgi Camblong

10b5-1 sale on July 10, 2026 8,500 shares for $47,791.25 Common stock 10b5-1 Sale for Jurgi Camblong

Key Terms

Form 144, Exercise of Stock Options, Founders Shares, 10b5-1 Sales

4 terms

Form 144 regulatory

"Filer Information | | | 144: Filer Information"

Form 144 is a document that investors must file with the government when they plan to sell a large number of shares of a company's stock. It helps ensure transparency so everyone knows how many shares are being sold and when, which can impact the stock's price.

Exercise of Stock Options financial

"Common | 07/20/2026 | Exercise of Stock Options | Issuer"

Founders Shares financial

"Common | 03/18/2021 | Founders Shares | Issuer"

Founders shares are a special block of a company’s stock originally given to the people who started the business; they often carry extra voting power or favorable terms compared with regular shares. For investors, these shares matter because they concentrate control and influence how future funding, ownership dilution, and decision-making will play out—think of founders shares as the steering wheel that can steer a company’s direction even as more passengers (investors) climb aboard.

10b5-1 Sales regulatory

"10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle"

10b5-1 sales are pre-arranged stock-trading plans that let company insiders automatically buy or sell shares according to a fixed schedule or formula, even if they later learn confidential information. Think of it as setting up an automatic thermostat for trades: it creates a clear, documented path that can protect insiders from insider-trading accusations and gives investors a signal about predictable insider activity—though it can also simply be a way for insiders to diversify or raise cash.

FAQ

AI-generated questions and answers. How Rhea-AI works. Not financial advice.

What stock sales does the SOPH Form 144 disclose?

The Form 144 for SOPH discloses a planned sale of 4,581 shares from an exercise of stock options and 19,800 founder shares, both in common stock, by insider Jurgi Camblong through a brokerage firm.

How many SOPH shares are tied to stock option exercises in this notice?

The filing shows 4,581 SOPH common shares will be sold in connection with an Exercise of Stock Options dated July 20, 2026, as part of the insider’s disclosed planned transactions.

What founder shares of SOPH are included in the planned sales?

The notice lists 19,800 founder shares of SOPH common stock dated March 18, 2021. These founder shares are included in the overall amount that the insider indicates may be sold under the Form 144.

What recent 10b5-1 plan sales in SOPH stock are disclosed?

Recent Rule 10b5-1 sales include 65,269 shares for $398,632.27 on June 30, 2026 and 50,069 shares for $290,329.01 on June 26, 2026, along with several smaller trades in May, June, and July 2026.

Who is the broker handling the SOPH insider’s planned stock sales?

The planned SOPH stock sales are arranged through Morgan Stanley Smith Barney LLC Executive Financial Services, located at 1 New York Plaza, 8th Floor, New York, NY 10004.

Are the recent SOPH stock sales made under a trading plan?

Yes. The document describes multiple transactions as 10b5-1 Sales for Jurgi Camblong, indicating they were executed under a pre-arranged Rule 10b5-1 trading plan for SOPH common stock.

AI-generated analysis. How Rhea-AI works. Not financial advice.

See more from StockTitan in Google Search and AI answers. Adds StockTitan as a preferred source · opens Google

Add on Google Not now

Accepted by SEC EDGAR 07/20/2026 - 04:15 PM EDT Learn about SEC filing dates

Form 144 Filer Information	UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 Form 144 NOTICE OF PROPOSED SALE OF SECURITIES PURSUANT TO RULE 144 UNDER THE SECURITIES ACT OF 1933
FORM 144

144: Filer Information

Filer CIK	0002007050
Filer CCC	XXXXXXXX
Is this a LIVE or TEST Filing?	LIVE TEST
Submission Contact Information
Name
Phone
E-Mail Address

144: Issuer Information

Name of Issuer	SOPHIA GENETICS SA
SEC File Number	001-40627
Address of Issuer	La Piece 12 ch-1180 Rolle SWITZERLAND 00000
Phone	41216941060
Name of Person for Whose Account the Securities are To Be Sold	JURGI CAMBLONG
See the definition of "person" in paragraph (a) of Rule 144. Information is to be given not only as to the person for whose account the securities are to be sold but also as to all other persons included in that definition. In addition, information shall be given as to sales by all persons whose sales are required by paragraph (e) of Rule 144 to be aggregated with sales for the account of the person filing this notice.
Relationship to Issuer	Director
Relationship to Issuer	Officer

144: Securities Information

Title of the Class of Securities To Be Sold	Name and Address of the Broker	Number of Shares or Other Units To Be Sold	Aggregate Market Value	Number of Shares or Other Units Outstanding	Approximate Date of Sale	Name the Securities Exchange
Common	Morgan Stanley Smith Barney LLC Executive Financial Services 1 New York Plaza 8th Floor New York NY 10004	24381	143116.47	71790366	07/20/2026	NASDAQ

Furnish the following information with respect to the acquisition of the securities to be sold and with respect to the payment of all or any part of the purchase price or other consideration therefor:

144: Securities To Be Sold

Title of the Class	Date you Acquired	Nature of Acquisition Transaction	Name of Person from Whom Acquired	Is this a Gift?	Date Donor Acquired	Amount of Securities Acquired	Date of Payment	Nature of Payment *
Common	07/20/2026	Exercise of Stock Options	Issuer			4581	07/20/2026	Cash
Common	03/18/2021	Founders Shares	Issuer			19800	03/18/2021	N/A

* If the securities were purchased and full payment therefor was not made in cash at the time of purchase, explain in the table or in a note thereto the nature of the consideration given. If the consideration consisted of any note or other obligation, or if payment was made in installments describe the arrangement and state when the note or other obligation was discharged in full or the last installment paid.

Furnish the following information as to all securities of the issuer sold during the past 3 months by the person for whose account the securities are to be sold.

144: Securities Sold During The Past 3 Months

Name and Address of Seller	Title of Securities Sold	Date of Sale	Amount of Securities Sold	Gross Proceeds
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	07/10/2026	8500	47791.25
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	07/07/2026	17685	93327.28
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	07/06/2026	22486	118163.93
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	06/30/2026	65269	398632.27
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	06/29/2026	18410	108058.02
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	06/26/2026	50069	290329.01
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	06/25/2026	1373	7826.10
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	06/10/2026	8500	44500.90
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	05/19/2026	4486	20657.58
10b5-1 Sales for JURGI CAMBLONG La Piece 12 ch-1180 Rolle V8 00000	Common	05/11/2026	8500	43241.20

144: Remarks and Signature

Remarks
Date of Notice	07/20/2026
Date of Plan Adoption or Giving of Instruction, If Relying on Rule 10b5-1	08/28/2025
ATTENTION:
The person for whose account the securities to which this notice relates are to be sold hereby represents by signing this notice that he does not know any material adverse information in regard to the current and prospective operations of the Issuer of the securities to be sold which has not been publicly disclosed. If such person has adopted a written trading plan or given trading instructions to satisfy Rule 10b5-1 under the Exchange Act, by signing the form and indicating the date that the plan was adopted or the instruction given, that person makes such representation as of the plan adoption or instruction date.
Signature	/s/ Jurgi Camblong
ATTENTION: Intentional misstatements or omission of facts constitute Federal Criminal Violations (See 18 U.S.C. 1001)